شنبه 17 خرداد 1404
[Archive]
دوره ۲۶، شماره ۱۱۵ - ( ۳-۱۳۹۷ )
جلد ۲۶ شماره ۱۱۵ صفحات ۲۱-۱۲ |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Akya A, Elahi A, Chegeneh Lorestani R, Ghadiri K. The Role of AcrAB Leakage Pump in Resistance to Fluoroquinolones in Klebsiella Pneumoniae Isolates Collected from Medical Centers of Kermanshah. J Adv Med Biomed Res 2018; 26 (115) :12-21
URL: http://journal.zums.ac.ir/article-1-5046-fa.html
URL: http://journal.zums.ac.ir/article-1-5046-fa.html
اکیا علی شا، الهی اعظم، چگنه لرستانی رویا، قدیری کیقباد. نقش پمپ تراوشی AcrAB در مقاومت به فلوروکینولون‌ها در جدایه‌های کلبسیلا پنومونیه جمع آوری شده از مراکز پزشکی کرمانشاه. Journal of Advances in Medical and Biomedical Research. ۱۳۹۷; ۲۶ (۱۱۵) :۱۲-۲۱
علی شا اکیا۱ 
، اعظم الهی*۲ ، رویا چگنه لرستانی۳ ، کیقباد قدیری۴
، اعظم الهی*۲ ، رویا چگنه لرستانی۳ ، کیقباد قدیری۴
۱- دکترای تخصصی باکتری شناسی، دانشیار مرکز تحقیقات عفونت‌های بیمارستانی، دانشگاه علوم پزشکی کرمانشاه، کرمانشاه
۲- کارشناسی ارشد میکروب‌شناسی، دانشکده‌ی پزشکی، دانشگاه علوم پزشکی کرمانشاه، کرمانشاه ،azamelahi1365@gmail.com
۳- کارشناسی ارشد میکروب‌شناسی، دانشکده‌ی پزشکی، دانشگاه علوم پزشکی کرمانشاه، کرمانشاه
۴- فوق تخصص بیماری‌های عفونی کودکان، دانشیار مرکز تحقیقات عفونت‌های بیمارستانی، دانشگاه علوم پزشکی کرمانشاه، کرمانشاه
۲- کارشناسی ارشد میکروب‌شناسی، دانشکده‌ی پزشکی، دانشگاه علوم پزشکی کرمانشاه، کرمانشاه ،
۳- کارشناسی ارشد میکروب‌شناسی، دانشکده‌ی پزشکی، دانشگاه علوم پزشکی کرمانشاه، کرمانشاه
۴- فوق تخصص بیماری‌های عفونی کودکان، دانشیار مرکز تحقیقات عفونت‌های بیمارستانی، دانشگاه علوم پزشکی کرمانشاه، کرمانشاه
چکیده: (۱۵۴۲۰۵ مشاهده)
Background and Objective: One of the mechanisms involved in the resistance of Klebsiella pneumoniae to fluoroquinolones is AcrAB leakage pumps. In this study, the prevalence of Klebsiella pneumoniae isolates with AcrAB encoding genes and the role of permeation pumps in fluoroquinolone resistance were investigated.
Materials and Methods: 165 samples from patients of Kermanshah Medical Centers were collected and 100 isolates of Klebsiella pneumoniae approved by API-20E kit. Antibiotic susceptibility of isolates to ciprofloxacin and levofloxacin was determined using disk diffusion and MIC (Minimum Inhibitory Concentration) experiments. AcrA and AcrB genes were determined by PCR method. The effect of bacterial permeation inhibitor (CCCP) Carbonyl cyanide m-chlorophynyl hydrazone with final concentration of 5μg / ml on MIC of fluoroquinolones resistant isolates was done using agar dilution method.
Results: Of the100 Klebsiella pneumoniae isolates, 28 (28%), were resistant to ciprofloxacin and levofloxacin. Both acrA and acrB genes were resistant to antibiotics in all Klebsiella pneumoniae isolates. The effect of CCCP on isolates resistant to ciprofloxacin and levofloxacin resulted in a decrease in MIC in 11 isolates (39.2%), among which the MIC was changed in five isolated from resistant to susceptible state.
Conclusion: Although the high drug resistance of isolates is not due to permeation pumps, the results of inhibition of pump indicate their role in the resistance of 39% of isolates. Also, the presence of AcrAB genes in all fluoroquinolones resistant Klebsiella pneumoniae isolates shows the importance of these pumps.
نوع مطالعه: کارآزمایی بالینی |
دریافت: 1396/11/16 | پذیرش: 1396/11/16 | انتشار: 1396/11/16
دریافت: 1396/11/16 | پذیرش: 1396/11/16 | انتشار: 1396/11/16
فهرست منابع
1. Feiz Sardhar MH, Akya A. The Frequency of Extended Spectrum β-Lactamase Genes of SHV-2a, SHV-5 and SHV-12 in Clinical Isolates of Klebsiella Pneumoniae Isolated from Kermanshah Medical Centers in 2014. Arak Uni Med Sci. 2016; 19: 59-67.
2. Akya A, Khodadoost M, Rashiditabar E. Prevalence of blaTEM Gene in Escherichia coli Isolated from Urinary Tract Infections of Outpatients in Kermanshah. Zanjan Uni Med Sci. 2013; 21: 84-94.
3. Sarkozy G. Quinolone:a class of antimicrobial agents. Vet Med. 2001; 46: 257-74. [DOI:10.17221/7883-VETMED]
4. Hooper DC. Emerging mechanisms of fluoroquinolone resistance. Emerg Infect Dis. 2001; 7: 337-41. [DOI:10.3201/eid0702.010239] [PMID] [PMCID]
5. Wada K, Kariyama R, Mitsuhata R, et al. Experimental and clinical studies on fluoroquinolone-insusceptible Escherichia coli isolated from patients with urinary tract infections from 1994 to 2007. Acta medica Okayama. 2009; 63: 263-72.
6. Yamane K, Wachino J, Suzuki S, et al. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob Agents Chemother. 2007; 51: 3354-60. [DOI:10.1128/AAC.00339-07] [PMID] [PMCID]
7. Koronakis V. TolC--the bacterial exit duct for proteins and drugs. FEBS letters. 2003; 555: 66-71. [DOI:10.1016/S0014-5793(03)01125-6]
8. Levy SB. Active efflux, a common mechanism for biocide and antibiotic resistance. J Appl Microbiol. 2002; 92: 65S-71S. [DOI:10.1046/j.1365-2672.92.5s1.4.x]
9. Goudarzi H, Doraghi M, Dabiri H, Ghalavand Z. Functional analysis of multidrug efflux pumps genes of Acinetobacter baumannii strains. Research in Medicine. 2013; 37: 107-12.
10. Peleg AY, Adams J, Paterson DL. Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii. Antimicrob Agents Chemother. 2007; 51: 2065-9. [DOI:10.1128/AAC.01198-06] [PMID] [PMCID]
11. Saadatian Farivar A, Nowroozi J, Eslami G, Sabokbar A, Hashemi A. The study of antibiotic resistance among Klebsiella pneumoniae and expression level of oqxA and acrA genes by using real-time PCR. Shahid Beheshti Uni Med Sci. 2016; 40: 42-8.
12. Eswaran J, Koronakis E, Higgins MK, Hughes C, Koronakis V. Thr ee's company: component structures bring a closer view of tripartite drug efflux pumps. Curr Opin Struct Biol. 2004; 14: 741-7. [DOI:10.1016/j.sbi.2004.10.003] [PMID]
13. Koronakis V, Eswaran J, Hughes C. Structure and function of TolC: the bacterial exit duct for proteins and drugs. Annu Rev Biochem. 2004; 73: 467-89. [DOI:10.1146/annurev.biochem.73.011303.074104] [PMID]
14. Oethinger M, Kern WV, Jellen-Ritter AS, McMurry LM, Levy SB. Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob Agents Chemother. 2000; 44: 10-3. [DOI:10.1128/AAC.44.1.10-13.2000] [PMID] [PMCID]
15. Putman M, van Veen HW, Konings WN. Molecular properties of bacterial multidrug transporters. Microbiol Mol Biol Rev. 2000; 64: 672-93. [DOI:10.1128/MMBR.64.4.672-693.2000] [PMID] [PMCID]
16. Saenz Y, Ruiz J, Zarazaga M, Teixido M, Torres C, Vila J. Effect of the efflux pump inhibitor Phe-Arg-beta-naphthylamide on the MIC values of the quinolones, tetracycline and chloramphenicol, in Escherichia coli isolates of different origin. J Antimicrob Chemother. 2004; 53: 544-5. [DOI:10.1093/jac/dkh117] [PMID]
17. Tarashi S, Goudarzi H, Hashemi A, et al. Evaluation of carbonyl cyanide 3-chlorophenyl hydrazone effect and efflux pump expression level of mexCD-oprJ among Pseudomonas aeruginosa strains isolated from hospitalized patients in Shahid Motahari hospital in Tehran during 2014-2015. Zanjan Uni Med Sci J. 2016; 108: 43-55.
18. Zhong HQ, Zhang S, Pan H, Cai T. Influence of induced ciprofloxacin resistance on efflux pump activity of Klebsiella pneumoniae. J Zhejiang Univ Sci B. 2013; 14: 837-43. [DOI:10.1631/jzus.B1200221] [PMID] [PMCID]
19. Pakzad I, Zayyen Karin M, Taherikalani M, Boustanshenas M, Lari AR. Contribution of AcrAB efflux pump to ciprofloxacin resistance in Klebsiella pneumoniae isolated from burn patients. GMS Hyg Infect Control. 2013; 8: 1-6.
20. Clinical and Laboratory Standards Institute (CLSI), 2011. Performance Standards for Antimicrobial Susceptibility Testing; Twenty- Fourth Informational Supplement. CLSI, Wayne, PA. M100-S21, 31, no. 1. 2011.
21. Nascente PS, Meineraz ARM, Faria RO, Suchuch LF, Meireles MCA, Mello JRB. CLSI broth microdilution method for testing susceptibility of Malasseziapachydermatis to thiabendazole. Braz J Microbiol. 2009; 40: 222-6. [DOI:10.1590/S1517-83822009000200002] [PMID] [PMCID]
22. Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?. Clin Infect Dis. 2002; 34: 634-40. [DOI:10.1086/338782] [PMID]
23. Stavri M, Piddock LJ, Gibbons S. Bacterial efflux pump inhibitors from natural sources. J Antimicrob Chemother. 2007; 59: 1247-60. [DOI:10.1093/jac/dkl460] [PMID]
24. Yedekci S, Erac B, Limoncu MH. Detection of the efflux pump-mediated quinolone resistance in ESBL positive Escherichia coli and Klebsiella pneumoniae isolates by phe-Arg-beta naphthylamide. Turk J Pharm Sci. 2012; 9: 67-74.
25. Mazzariol A, Tokue Y, Kanegawa TM, Cornaglia G, Nikaido H. High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA. Antimicrob Agents Chemother. 2000; 44: 3441-3. [DOI:10.1128/AAC.44.12.3441-3443.2000] [PMID] [PMCID]
26. Martinez-Martinez L, Pascual A, Conejo Mdel C, et al. Energy-dependent accumulation of norfloxacin and porin expression in clinical isolates of Klebsiella pneumoniae and relationship to extended-spectrum beta-lactamase production. Antimicrob Agents Chemother. 2002; 46: 3926-32. [DOI:10.1128/AAC.46.12.3926-3932.2002] [PMID] [PMCID]
27. Hasdemir UO, Nordmann P, Pages JM. Detection and prevalence of active drug efflux mechanism in various multidrug-resistant Klebsiella pneumoniae strains from Turkey. J Clin Microbiol. 2004: 2701-6. [DOI:10.1128/JCM.42.6.2701-2706.2004] [PMID] [PMCID]
28. Kishk R, Mandour M, Hessam W, Nemr N. Efflux pump genes and chlorhexidine resistance: Clue for Klebsiella pneumoniae infections in intensive care units, Egypt. Afr J Microbiol Res. 2014; 8: 2162-7. [DOI:10.5897/AJMR2014.6656]
29. Andersen JL, He GX, Kakarla P, et al. Multidrug efflux pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogens. Int J Environ Res Public Health. 2015; 12: 1487-1547. [DOI:10.3390/ijerph120201487] [PMID] [PMCID]
ارسال پیام به نویسنده مسئول
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
